• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

ReNeuron Provides Business Update and Results Notification
Second Cohort of Phase 2a Study in Retinitis Pigmentosa Dosing Complete LONDON, May 8, 2019 -- (Healthcare Sales & Marketing Network) -- ReNeuron Group plc (AIM: RENE), a global leader in the development of cell-based therapeutics, announced a year-end... Regenerative Medicine, Ophthalmology, Neurology ReNeuron Group, retinitis pigmentosa, stroke, stem cell
Source: HSMN NewsFeed - May 8, 2019 Category: Pharmaceuticals Source Type: news

Creative Medical Technology Holdings Files Patent on AmnioStem Stroke Therapy
PHOENIX and SAN DIEGO, Dec. 13, 2016 -- (Healthcare Sales & Marketing Network) -- Creative Medical Technology Holdings (the "Company") (CELZ) announced today filing of US patent application #62/400557 entitled "Treatment of Stroke by Amniot... Regenerative Medicine, Neurology Creative Medical Technology, AmnioStem, stem cell, exosomes, stroke
Source: HSMN NewsFeed - December 13, 2016 Category: Pharmaceuticals Source Type: news

BioTime Enters into Worldwide License Agreement with UCLA to Develop Therapy for the Treatment of Stroke
ALAMEDA, Calif.--(Healthcare Sales & Marketing Network)--BioTime, Inc. (NYSE MKT: BTX) today announced that it has entered into an exclusive license agreement with the University of California, Los Angeles (UCLA) for novel technology related to the treatme... Regenerative Medicine, Neurology, LicensingBioTime, HyStem hydrogel, stroke, stem cell
Source: HSMN NewsFeed - April 19, 2013 Category: Pharmaceuticals Source Type: news